Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q3 2015 · 10-Q
Revenue$219.11K$219.11K+56.8% vs Q3 2014 Net Income-$18.92K-$18.92KN/M vs Q3 2014 EPS Diluted$0.00$0.00— vs Q3 2014 Gross Profit$100,030+16.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flowderived$5,121N/M Free Cash Flowderived$432— Margins · derivedGross margin45.7%−15.9 pt vs Q3 2014
Operating margin-9.0%−4.6 pt vs Q3 2014
Net margin-8.6%−3.9 pt vs Q3 2014
ended Sep 30, 2015 · filed Oct 27, 2016 · 393 d after period end